Evidence map›Paper›PMID 24129513›Full record

ArticleThe EMBO journal2013

Endonuclease G mediates α-synuclein cytotoxicity during Parkinson's disease.

Sabrina Büttner, Lukas Habernig, Filomena Broeskamp, Doris Ruli, F Nora Vögtle, Manolis Vlachos, Francesca Macchi, Victoria Küttner, Didac Carmona-Gutierrez, Tobias Eisenberg and 19 more

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNAProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. A Brief Review on Caenorhabditis elegans Role in Modelling Neurodegenerative Disease.Central nervous system agents in medicinal chemistry · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Biomolecules · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Modeling Parkinson's Disease: Not Only Rodents?Frontiers in aging neuroscience · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 8 institutions in 5 countries.

Sabrina Büttner1] Institute of Molecular Biosciences, University of Graz, Graz, Austria [2] Institute for Biology/Genetics, Freie Universität Berlin, Berlin, Germany.
Lukas Habernig
Filomena Broeskamp
Doris Ruli
F Nora Vögtle
Manolis Vlachos
Francesca Macchi
Victoria Küttner
Didac Carmona-Gutierrez
Tobias Eisenberg
Julia Ring
Maria Markaki
Asli Aras Taskin
Stefan Benke
Christoph Ruckenstuhl
Ralf Braun
Chris Van den Haute
Tine Bammens
Anke van der Perren
Kai-Uwe Fröhlich
Joris Winderickx
Guido Kroemer
Veerle Baekelandt
Nektarios Tavernarakis
Gabor G Kovacs
Jörn Dengjel
Chris Meisinger
Stephan J Sigrist
Frank Madeo
University of Graz · ATKU Leuven · BEUniversity of Freiburg · DEFoundation for Research and Technology Hellas · GRFreie Universität Berlin · DEHôpital Européen Georges-Pompidou · FRMedical University of Vienna · ATUniversity of Bayreuth · DE

Funding

Austrian Science Fund FWF I 1000Austrian Science Fund FWF P 23490Austrian Science Fund FWF V 235Austrian Science Fund FWF W 1226
6 · The paper itself

Abstract

Malfunctioning of the protein α-synuclein is critically involved in the demise of dopaminergic neurons relevant to Parkinson's disease. Nonetheless, the precise mechanisms explaining this pathogenic neuronal cell death remain elusive. Endonuclease G (EndoG) is a mitochondrially localized nuclease that triggers DNA degradation and cell death upon translocation from mitochondria to the nucleus. Here, we show that EndoG displays cytotoxic nuclear localization in dopaminergic neurons of human Parkinson-diseased patients, while EndoG depletion largely reduces α-synuclein-induced cell death in human neuroblastoma cells. Xenogenic expression of human α-synuclein in yeast cells triggers mitochondria-nuclear translocation of EndoG and EndoG-mediated DNA degradation through a mechanism that requires a functional kynurenine pathway and the permeability transition pore. In nematodes and flies, EndoG is essential for the α-synuclein-driven degeneration of dopaminergic neurons. Moreover, the locomotion and survival of α-synuclein-expressing flies is compromised, but reinstalled by parallel depletion of EndoG. In sum, we unravel a phylogenetically conserved pathway that involves EndoG as a critical downstream executor of α-synuclein cytotoxicity.

Indexed as

ApoptosisAgedalpha-SynucleinAnimalsCaenorhabditis elegansDNA DamageDopamineDrosophila melanogasterEndodeoxyribonucleasesHumansImmunoblottingImmunoenzyme TechniquesMitochondriaNeuroblastomaNeuronsOxidative Stressalpha-SynucleinDopamineEndodeoxyribonucleasesendonuclease GRNA, Messenger

Identifiers

PMID24129513
PMCPMC3844953
OpenAlexW1769600480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.